Mental Health Clinics in Tea, SD Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Good Karma Wellness, Llc Psychologist Medicare: Not Enrolled in Medicare Practice Location: 910 Cathy Dr, Tea, SD 57064 Phone: 507-213-6171 |
Life Balance Counseling And Services Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 46677 Canary Pl, Tea, SD 57064 Phone: 402-290-5742 |
Truth & Grace Counseling Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 125 W 1st St, Tea, SD 57064 Phone: 605-777-1898 Fax: 605-777-1899 |
Shift, Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 26946 464th Ave, Tea, SD 57064 Phone: 701-830-0388 |
Linc Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 310 S Prairie Ave, Tea, SD 57064 Phone: 952-239-6485 |
News Archive
Mississippi Medicaid fraud-prevention rule criticized for eliminating beneficiaries from program
Mississippi state lawmakers last week rejected efforts to repeal a state rule requiring Medicaid beneficiaries to show up in person to renew their enrollment each year, the AP/Miami Herald reports.
Scientists identify 'de novo' genetic mutations in autism spectrum disorder children
Scientists at the University of Washington (UW) Department of Genome Sciences have identified several sporadic or "de novo" genetic mutations in children with autism spectrum disorder. The researchers applied leading edge molecular biology techniques and massively parallel sequencing to simultaneously examine all of the protein coding portions of the genome, collectively called the exome.
FDA clears Hotspur's new balloon dilatation and embolectomy catheters
Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.
Novelos continues NOV-002 Phase 3 combination trial for lung cancer
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
Messersmith Research Group at UC Berkeley use NanoWizard®3a AFM and ForceRobot systems to study biologically inspired polymer adhesives
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the use of their NanoWizard®3a AFM and ForceRobot systems by the Messersmith Research Group at UC Berkeley to study biologically inspired polymer adhesives.
› Verified 7 days ago